BioCentury | Jun 12, 2006
Strategy

Back in the limelight

...In 2000, ThromboGenics in-licensed microplasmin, which was discovered by different researchers at Katholieke. In 2001, East Hill Advisors...
BioCentury | Jun 5, 2006
Finance

Ebb & Flow

...could be aiming to raise about E40 million ($51 million). ThromboGenics raised $12.8 million from East Hill Advisors...
BioCentury | May 10, 2001
Financial News

ThromboGenics raises $12.8 million

...ThromboGenics (Dublin, Ireland) raised $12.8 million in a private financing with East Hill Advisors. ThromboGenics is developing compounds...
Items per page:
1 - 3 of 3
BioCentury | Jun 12, 2006
Strategy

Back in the limelight

...In 2000, ThromboGenics in-licensed microplasmin, which was discovered by different researchers at Katholieke. In 2001, East Hill Advisors...
BioCentury | Jun 5, 2006
Finance

Ebb & Flow

...could be aiming to raise about E40 million ($51 million). ThromboGenics raised $12.8 million from East Hill Advisors...
BioCentury | May 10, 2001
Financial News

ThromboGenics raises $12.8 million

...ThromboGenics (Dublin, Ireland) raised $12.8 million in a private financing with East Hill Advisors. ThromboGenics is developing compounds...
Items per page:
1 - 3 of 3